Literature DB >> 14607853

Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury.

Felice Beitzel1, Paul Gregorevic, James G Ryall, David R Plant, Martin N Sillence, Gordon S Lynch.   

Abstract

Beta(2)-adrenoceptor agonists such as fenoterol are anabolic in skeletal muscle, and because they promote hypertrophy and improve force-producing capacity, they have potential application for enhancing muscle repair after injury. No previous studies have measured the beta(2)-adrenoceptor population in regenerating skeletal muscle or determined whether fenoterol can improve functional recovery in regenerating muscle after myotoxic injury. In the present study, the extensor digitorum longus (EDL) muscle of the right hindlimb of deeply anesthetized rats was injected with bupivacaine hydrochloride, which caused complete degeneration of all muscle fibers. The EDL muscle of the left hindlimb served as the uninjured control. Rats received either fenoterol (1.4 mg x kg(-1) x day(-1)) or an equal volume of saline for 2, 7, 14, or 21 days. Radioligand binding assays identified a approximately 3.5-fold increase in beta(2)-adrenoceptor density in regenerating muscle at 2 days postinjury. Isometric contractile properties of rat EDL muscles were measured in vitro. At 14 and 21 days postinjury, maximum force production (P(o)) of injured muscles from fenoterol-treated rats was 19 and 18% greater than from saline-treated rats, respectively, indicating more rapid restoration of function after injury. The increase in P(o) in fenoterol-treated rats was due to increases in muscle mass, fiber cross-sectional area, and protein content. These findings suggest a physiological role for beta(2)-adrenoceptor-mediated mechanisms in muscle regeneration and show clearly that fenoterol hastens recovery after injury, indicating its potential therapeutic application.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607853     DOI: 10.1152/japplphysiol.01081.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  28 in total

1.  Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Authors:  James G Ryall; Martin N Sillence; Gordon S Lynch
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  CL 316,243, a selective beta3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle.

Authors:  Luiz Carlos C Navegantes; Neusa M Z Resano; Amanda Martins Baviera; Renato H Migliorini; Isis C Kettelhut
Journal:  Pflugers Arch       Date:  2005-08-10       Impact factor: 3.657

Review 3.  cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration.

Authors:  Rebecca Berdeaux; Randi Stewart
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-21       Impact factor: 4.310

Review 4.  Myotoxicity of injections for acute muscle injuries: a systematic review.

Authors:  Gustaaf Reurink; Gert Jan Goudswaard; Maarten H Moen; Adam Weir; Jan A N Verhaar; Johannes L Tol
Journal:  Sports Med       Date:  2014-07       Impact factor: 11.136

5.  Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.

Authors:  James P White; Kristen A Baltgalvis; Shuichi Sato; L Britt Wilson; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

6.  β2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury.

Authors:  Natalie E Scholpa; Epiphani C Simmons; Douglas G Tilley; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2019-09-13       Impact factor: 5.330

7.  Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men.

Authors:  Morten Hostrup; Søren Reitelseder; Søren Jessen; Anders Kalsen; Michael Nyberg; Jon Egelund; Michael Kreiberg; Caroline Maag Kristensen; Martin Thomassen; Henriette Pilegaard; Vibeke Backer; Glenn A Jacobson; Lars Holm; Jens Bangsbo
Journal:  J Physiol       Date:  2018-07-30       Impact factor: 5.182

8.  Change of skeletal muscle mass in patients with pheochromocytoma.

Authors:  Seung Hun Lee; Mi Kyung Kwak; Seong Hee Ahn; Hyeonmok Kim; Yoon Young Cho; Sunghwan Suh; Kee-Ho Song; Jung-Min Koh; Jae Hyeon Kim; Beom-Jun Kim
Journal:  J Bone Miner Metab       Date:  2018-09-20       Impact factor: 2.626

9.  pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise.

Authors:  Anita Reddy; Luiz H M Bozi; Omar K Yaghi; Evanna L Mills; Haopeng Xiao; Hilary E Nicholson; Margherita Paschini; Joao A Paulo; Ryan Garrity; Dina Laznik-Bogoslavski; Julio C B Ferreira; Christian S Carl; Kim A Sjøberg; Jørgen F P Wojtaszewski; Jacob F Jeppesen; Bente Kiens; Steven P Gygi; Erik A Richter; Diane Mathis; Edward T Chouchani
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

10.  Activation of the β-adrenergic receptor exacerbates lipopolysaccharide-induced wasting of skeletal muscle cells by increasing interleukin-6 production.

Authors:  Shino Matsukawa; Shinichi Kai; Hideya Seo; Kengo Suzuki; Kazuhiko Fukuda
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.